Pharmacovigilance Software Market By Functionality (ADR Reporting Software, Drug Safety Audits, Issue Tracking, Fully Integrated Software), By Delivery Mode (On-Premise, On-Demand), By End-Use (Pharmaceutical & Biotech Companies, Cros, Bpos, Pharmacovigilance Providers, Academic Institutes, Government Authorities) And Segment Forecasts To 2024

Published: Oct, 2016 | Pages: 100 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global pharmacovigilance (PV) software market was valued at USD 117.3 million in 2015 and is expected to reach a value of USD 207.3 million by 2024. Increasing emphasis on regulatory compliances by government entities such as the U.S. FDA, European Medical Agency, etc. coupled with supportive initiatives are anticipated to drive the PV software market over the forecast period.

Increasing demand for fully integrated systems in an attempt to avert errors in database management is a crucial factor responsible for the adoption of these systems. Moreover, associated benefits of cloud-based platforms, such as remote access to information, reduction of operational costs, and ease of access are factors contributing toward the market growth in the near future.

Further Key Findings From the Study Suggest:

ADR reporting tools dominated the overall pharmacovigilance software market on the basis of functionality in 2015, due to the related benefits such as data entry and management with minimum errors. On the other hand, demand for fully integrated platforms is increasing to track individual case safety reports and avoid data redundancy through the elimination of errors. The aforementioned factors are anticipated to contribute toward lucrative growth of fully integrated systems in PV.

On-demand software services, considered as cloud computing are expected to be the fastest growing service segment in the coming years due to its increasing adoption in the contract research organizations. Remote access to data, real-time data tracking, and a simpler complex physical ecosystem are the notable benefits associated with cloud-based systems.

CROs segment is expected to exhibit profitable growth during the forecast period due to the increasing trend of outsourcing. PV service providers, in an attempt, to ensure sustainability, are providing customized end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies, such as electronic data capture and hosting of PV warehousing to aggregate cross industry data, which enables risk evaluation. Furthermore, service providers are now operating via flexible and variable pricing structures to achieve operational excellence through constant product updates, which is expected to boost the usage rates over the next 7 years.

North America held the largest market share as of 2015, majorly owing to the government aided initiatives favoring the adoption of PV software systems. For instance, the Open FDA initiative provides scientists and application developers the access to its massive database through open search-based programs, which is anticipated to boost the usage rates over the forecast period. Mini-Sentinel is a project started by the U.S. FDA to promote active surveillance systems, which provide statistically relevant data in less time. The aforementioned initiatives strengthen the growth of the regional market

Many healthcare IT companies are shifting toward hosting of cloud-based platforms to gain an edge over the competition. Cloud-based technology helps in remote storage of large amounts of data to save free space on the devices and facilitates data retrieval as per client needs. The technology comprises 3 services including Platform as a Service (PaaS), Infrastructure as a Service (IaaS), and Software as a Service (SaaS)

The key players serving pharmacovigilance software market are ArisGlobal, Ennov Solutions Inc.,Oracle Corporation, AB Cube, Sparta Systems, Inc., Max Application, EXTEDO GmbH, Relsys, Online Business Applications, Inc., and United BioSource Corporation

 Table of Contents


Chapter 1 Research Methodology & Scope
                    1.1 Region Wise Market Calculation
                       1.1.1 Region Wise Market: Base Estimates
                       1.1.2 Global Market: CAGR Calculation
                    1.2 Region Based Segment Share Calculation
                    1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
                    4.1 Market Segmentation & Scope
                       4.1.1 Market driver analysis
                             4.1.1.1 Rising incidences of ADR
                             4.1.1.2 Globalization of pharmacovigilance
                             4.1.1.3 Increasing burden from regulatory authorities
                             4.1.1.4 Introduction of technologically advanced software services
                       4.1.2 Market restraint analysis
                             4.1.2.1 Expensive technology
                    4.2 Penetration & Growth Prospect Mapping
                    4.3 Pharmacovigilance Software - PESTLE Analysis
                    4.4 Industry Analysis - Porter's
Chapter 5 Market Categorization 1: Functionality Estimates & Trend Analysis
                    5.1 Pharmacovigilance Software Market: Functionality Movement Analysis
                    5.2 ADR Reporting Software
                       5.2.1 ADR reporting software market, 2013 - 2024 (USD Million)
                    5.3 Drug Safety Audits
                       5.3.1 Drug safety audits market, 2013 - 2024 (USD Million)
                    5.4 Issue Tracking
                       5.4.1 Issue tracking market, 2013 - 2024 (USD Million)
                    5.5 Fully Integrated Software
                       5.5.1 Fully integrated software market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: Delivery Mode Estimates & Trend Analysis
                    6.1 Pharmacovigilance Software Market: Delivery Mode Movement Analysis
                    6.2 On-premise
                       6.2.1 On-premise market, 2013 - 2024 (USD Million) 
                    6.3 On-demand
                       6.3.1 On-demand market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: End-use Estimates & Trend Analysis
                    7.1 Pharmacovigilance Software Market: End-use Movement Analysis
                    7.2 Pharma & Biotech Companies
                       7.2.1 Pharma & biotech companies market, 2013 - 2024 (USD Million)
                    7.3 CROs
                       7.3.1 CROs market, 2013 - 2024 (USD Million)
                    7.4 BPOs
                       7.4.1 BPOs market, 2013 - 2024 (USD Million)
                    7.5 Others
                       7.5.1 Others market, 2013 - 2024 (USD Million)
Chapter 8 Market Categorization 4: Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use
                    8.1 Pharmacovigilance Software Market Share by Region, 2015 & 2024
                    8.2 North America
                       8.2.1 North America pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.2.2 U.S.
                             8.2.2.1 U.S. pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.2.3 Canada
                             8.2.3.1 Canada pharmacovigilance software market, 2013 - 2024 (USD Million)
                    8.3 Europe
                       8.3.1 Europe pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.3.2 UK
                             8.3.2.1 UK pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.3.3 Germany
                             8.3.3.1 Germany pharmacovigilance software market, 2013 - 2024 (USD Million)
                    8.4 Asia Pacific
                       8.4.1 Asia Pacific Pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.4.2 Japan
                             8.4.2.1 Japan pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.4.3 China
                             8.4.3.1 China pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.4.4 India
                             8.4.4.1 India Pharmacovigilance software market, 2013 - 2024 (USD Million)
                    8.5 Latin America
                       8.5.1 Latin America Pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.5.2 Brazil
                             8.5.2.1 Brazil Pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.5.3 Mexico
                             8.5.3.1 Mexico Pharmacovigilance software market, 2013 - 2024 (USD Million)
                    8.6 MEA
                       8.6.1 MEA pharmacovigilance software market, 2013 - 2024 (USD Million)
                       8.6.2 South Africa
                             8.6.2.1 South Africa pharmacovigilance software market, 2013 - 2024 (USD Million)
Chapter 9 Competitive Landscape
                    9.1 Company Profiles
                       9.1.1 AB cube
                             9.1.1.1 Company Overview
                             9.1.1.2 Financial Performance
                             9.1.1.3 Product Benchmarking
                             9.1.1.4 Strategic Initiatives
                       9.1.2 Max Application
                             9.1.2.1 Company Overview
                             9.1.2.2 Financial Performance
                             9.1.2.3 Product Benchmarking
                             9.1.2.4 Strategic Initiatives
                       9.1.3 Ennov Solutions, Inc.
                             9.1.3.1 Company Overview
                             9.1.3.2 Financial Performance
                             9.1.3.3 Product Benchmarking
                             9.1.3.4 Strategic Initiatives
                       9.1.4 ArisGlobal
                             9.1.4.1 Company Overview
                             9.1.4.2 Financial Performance
                             9.1.4.3 Product Benchmarking
                             9.1.4.4 Strategic Initiatives
                       9.1.5 EXTEDO GmbH
                             9.1.5.1 Company Overview
                             9.1.5.2 Financial Performance
                             9.1.5.3 Product Benchmarking
                             9.1.5.4 Strategic Initiatives
                       9.1.6 Online Business Applications, Inc.
                             9.1.6.1 Company Overview
                             9.1.6.2 Financial Performance
                             9.1.6.3 Product Benchmarking
                             9.1.6.4 Strategic Initiatives
                       9.1.7 Oracle Corporation
                             9.1.7.1 Company Overview
                             9.1.7.2 Financial Performance
                             9.1.7.3 Product Benchmarking
                             9.1.7.4 Strategic Initiatives
                       9.1.8 Sparta Systems, Inc.
                             9.1.8.1 Company Overview
                             9.1.8.2 Financial Performance
                             9.1.8.3 Product Benchmarking
                             9.1.8.4 Strategic Initiatives
                       9.1.9 United BioSource Corporation
                             9.1.9.1 Company Overview
                             9.1.9.2 Financial Performance
                             9.1.9.3 Product Benchmarking
                             9.1.9.4 Strategic Initiatives
                       9.1.10 Relsys
                             9.1.10.1 Company Overview
                             9.1.10.2 Financial Performance
                             9.1.10.3 Product Benchmarking
                             9.1.10.4 Strategic Initiatives

List of Tables


TABLE 1 North America Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 2 North America pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 3 North America Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 4 U.S. Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 5 U.S. pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 6 U.S. Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 7 Canada Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 8 Canada pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 9 Canada Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 10 Europe Pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 11 Europe pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 12 Europe Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 13 UK pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 14 UK pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 15 UK Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 16 Germany pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 17 Germany pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 18 Germany Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 19 Asia Pacific pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 20 Asia Pacific pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 21 Asia Pacific pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 22 Japan pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 23 Japan ADR Reporting Software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 24 Japan Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 25 China pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 26 China pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 27 China pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 28 India pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 29 India pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 30 India pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 31 Latin America pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 32 Latin America pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 33 Latin America pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 34 Brazil pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 35 Brazil pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 36 Brazil pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 37 Mexico pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 38 Mexico pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 39 Mexico pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 40 MEA pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 41 MEA pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 42 MEA Pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)
TABLE 43 South Africa pharmacovigilance software market, by functionality, 2013 - 2024 (USD Million)
TABLE 44 South Africa pharmacovigilance software market, by delivery mode, 2013 - 2024 (USD Million)
TABLE 45 South Africa pharmacovigilance software market, by end-use, 2013 - 2024 (USD Million)